Progress in the treatment of gastric cancer in Japan over the last 50 years

There have been remarkable changes in gastric cancer treatments in Japan, resulting in superb improvement of prognosis in patients with this disease. In this paper, the last 50 years have been divided into three eras: before 1990; the 1990s; and the era of evidence, which means after 2000. Changes o...

Descripción completa

Detalles Bibliográficos
Autor principal: Sasako, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992673/
https://www.ncbi.nlm.nih.gov/pubmed/32021955
http://dx.doi.org/10.1002/ags3.12306
_version_ 1783492880175726592
author Sasako, Mitsuru
author_facet Sasako, Mitsuru
author_sort Sasako, Mitsuru
collection PubMed
description There have been remarkable changes in gastric cancer treatments in Japan, resulting in superb improvement of prognosis in patients with this disease. In this paper, the last 50 years have been divided into three eras: before 1990; the 1990s; and the era of evidence, which means after 2000. Changes of treatments and prognosis were analyzed by several factors, such as surgery, chemotherapy, informed consent, clinical trials, and others, as improvement of prognosis is not due to one factor but several ones influencing each other.
format Online
Article
Text
id pubmed-6992673
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69926732020-02-04 Progress in the treatment of gastric cancer in Japan over the last 50 years Sasako, Mitsuru Ann Gastroenterol Surg Review Articles There have been remarkable changes in gastric cancer treatments in Japan, resulting in superb improvement of prognosis in patients with this disease. In this paper, the last 50 years have been divided into three eras: before 1990; the 1990s; and the era of evidence, which means after 2000. Changes of treatments and prognosis were analyzed by several factors, such as surgery, chemotherapy, informed consent, clinical trials, and others, as improvement of prognosis is not due to one factor but several ones influencing each other. John Wiley and Sons Inc. 2020-01-30 /pmc/articles/PMC6992673/ /pubmed/32021955 http://dx.doi.org/10.1002/ags3.12306 Text en © 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Review Articles
Sasako, Mitsuru
Progress in the treatment of gastric cancer in Japan over the last 50 years
title Progress in the treatment of gastric cancer in Japan over the last 50 years
title_full Progress in the treatment of gastric cancer in Japan over the last 50 years
title_fullStr Progress in the treatment of gastric cancer in Japan over the last 50 years
title_full_unstemmed Progress in the treatment of gastric cancer in Japan over the last 50 years
title_short Progress in the treatment of gastric cancer in Japan over the last 50 years
title_sort progress in the treatment of gastric cancer in japan over the last 50 years
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992673/
https://www.ncbi.nlm.nih.gov/pubmed/32021955
http://dx.doi.org/10.1002/ags3.12306
work_keys_str_mv AT sasakomitsuru progressinthetreatmentofgastriccancerinjapanoverthelast50years

Ejemplares similares